Passions

Hiking

History Books

Games of all kinds

Experience

Philochem AG Announces up to $1.35 Billion License Agreement With RayzeBio

June 10, 2025

Cooley advised Philochem AG, a wholly owned subsidiary of the Philogen Group (Milan Stock Exchange: PHIL), on its definitive license agreement with RayzeBio, a wholly owned subsidiary of Bristol Myers Squibb (NYSE: BMY), granting RayzeBio exclusive worldwide rights to develop, manufacture and commercialize OncoACP3, a clinical-stage therapeutic and diagnostic agent targeting prostate cancer.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Joe Sandys
Special Counsel, London
Alexandra Paterson
Associate, London
Joseph Perry
Associate, Reston
J. Brian Stalter
Special Counsel, New York
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
David Burns
Special Counsel, Washington, DC
Megan Browdie
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Ann Bevitt
Partner, London
Rachel Thorn
Of counsel, New York
Dr. Jon Cousin
Partner, Washington, DC

Related Practices & Industries

BioNTech Announces Global Collaboration Agreement With Bristol Myers Squibb

June 3, 2025

Cooley advised BioNTech SE, a global biotechnology company pioneering next-generation immunotherapies, on its global co-development and co-commercialization collaboration agreement with Bristol Myers Squibb for BioNTech’s antibody candidate BNT327. The transaction includes a $1.5 billion upfront payment and $2 billion total in noncontingent anniversary payments through 2028.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
J. Brian Stalter
Special Counsel, New York
John Forrest
Associate, Boston
Arda Can Tekin
Associate, New York
Megan Browdie
Partner, Washington, DC
David Burns
Special Counsel, Washington, DC
Jonas Koponen
Partner, Brussels
Rachel Thorn
Of counsel, New York
Eric Blanchard
Partner, Boston
Christopher Kimball
Partner, Washington, DC
Joe Sandys
Special Counsel, London
Natasha Leskovsek
Of Counsel, Washington, DC
Navya Dasari
Associate, New York
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

Aclaris Therapeutics Announces Global License Agreement With Biosion, $80 Million Private Placement

November 18, 2024

Cooley advised Aclaris Therapeutics (Nasdaq: ACRS), a clinical-stage biopharmaceutical company developing novel drug candidates for immuno-inflammatory diseases, on its exclusive license agreement with Biosion and $80 million private placement.

Read more

Related contacts

Mark Ballantyne
Partner, Reston
Kenneth Krisko
Partner, Reston
Brian Leaf
Partner, Reston
J. Brian Stalter
Special Counsel, New York
Ruomu Li
Partner, Shanghai
David Brinton
Associate, Washington, DC
Arjan Ganji
Associate, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Daniel I. Goldberg
Partner, New York
Christopher Kimball
Partner, Washington, DC
Aaron Pomeroy
Partner, Colorado
Francis Wheeler
Senior Counsel, Colorado
Rebecca Ross
Special Counsel, Washington, DC
John Forrest
Associate, Boston
Zack Gong
Associate, Shanghai
Michael Shen
Special Counsel, Shanghai
Robin K. Lee
Paralegal Specialist, Colorado

Related Practices & Industries

Carmot Therapeutics Enters Definitive Merger Agreement With Roche

December 3, 2023

Cooley advised Carmot Therapeutics, a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases including obesity and diabetes, on its definitive merger agreement in which Roche will acquire Carmot.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Charity Williams
Partner, San Diego
David Peinsipp
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Lauren Creel
Partner, Palo Alto
Howard Morse
Senior Counsel, Washington, DC
Xander Lee
Partner, Santa Monica
Ross Eberly
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
TJ Graham
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Tracy Rubin
Partner, Palo Alto
Phil Mitchell
Partner, New York
Charlie Kim
Partner, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Christine Graham
Special Counsel, London
Stella Sarma
Partner, Brussels
J. Brian Stalter
Special Counsel, New York
Grant Schweikert
Special Counsel, Washington, DC
Dani Nazemian
Special Counsel, San Diego
Annie Froehlich
Partner, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
Sangitha Palaniappa
Associate, Palo Alto
Tyler Saavedra-Buckley
Associate, San Francisco
Rubin Waranch
Associate, Colorado
Jameson Davis
Associate, Boston
Alexander Ellebracht
Associate, Palo Alto
Athina Gaki
Associate, Brussels
Andy Zachrich
Associate, San Francisco
Umer Chaudhry
Associate, Washington, DC
Jane Jun
Associate, Palo Alto
Samara Zaifman
Associate, Palo Alto
Carly E. Gibbons
Associate, Chicago
Claire Norman
Associate, Palo Alto
Kristina Krasnikova
Associate, Palo Alto
Patricia Myers
Paralegal Specialist, Colorado
Loraine Torres
Paralegal Specialist, Colorado
Hitesh Patel
eDiscovery Attorney, Washington, DC

Related Practices & Industries

Immatics Announces Collaboration With Moderna

September 11, 2023

Cooley advised Immatics, a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, on its strategic collaboration with Moderna.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Stephanie Parker Palmer
Special Counsel, Reston
J. Brian Stalter
Special Counsel, New York
Carly Robinson
Associate, Reston
David D. Suh
Associate
Freddy Yip
Associate, Hong Kong
Sharon Connaughton
Special Counsel, Washington, DC
Rubin Waranch
Associate, Colorado
Stella Sarma
Partner, Brussels
Kimberly Nguyen
Special Counsel, Reston
Liza Hadley
Associate, Boston
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
Rachel Thorn
Of counsel, New York

Related Practices & Industries

View more

Admissions and credentials

New York

New Jersey

Michigan